NA Proactive news snapshot: Blockchain Holdings Ltd, MGX Minerals Inc, HIRE Technologies Inc, Japan Gold Corp, Maverix Metals Inc, Lexaria Bioscience Corp, Hill Street Beverage Company Inc, Phunware Inc, Codebase Ventures Inc, PreveCeutical Medical Inc UP

A glance at some of the day’s highlights from the Proactive Investors US and Canada newswires

() announced Monday that its subsidiary TraceSafe Technologies Inc is teaming up with the Toronto Wolfpack Rugby League football team to help facilitate the club’s return to the field. Under an exclusive contract for the upcoming 2020-2021 season, TraceSafe will supply its iMSafe wearable tracing products to staff and fans attending the club’s home games at Lamport Stadium in Toronto while social distancing restrictions are in place. TraceSafe is a full suite of real-time location management services and contact tracing technology that is currently in use by governments and private enterprises to help manage the coronavirus outbreak.

MGX Minerals Inc () (OTCPINK:MGXMF) announced Monday that a field crew has reached the Heino-Money gold deposit mine portal and drill core storage area in British Columbia.The Vancouver-based company said the field crew has identified over 30 drill core storage racks, containing up to 10 x 10 drill core storage boxes each. A vast amount of core appears to be labeled, organized by year and in good condition with visible mineralization. In excess of 400 diamond drill holes, representing over 40,000 meters, are reported to have been completed by previous owners, approximately half of which were drilled from five levels of underground development. Heino-Money, which the company acquired last month, was active between 1981 and 1993 and produced around 5,800 tons of gold and silver ore. 

HIRE Technologies Inc () posted first-quarter results that saw “highly resilient” revenue as it continued to provide companies with IT, finance and back-office staff during the coronavirus (COVID-19) pandemic. For its first quarter ended March 31, 2020, the Toronto-based staffing company posted revenue of $2,902,786, which was only slightly lower than $3,011,887 clocked up for the same period a year earlier. Significantly, HIRE posted adjusted EBITDA, or earnings before interest, taxes, depreciation, and amortization of $50,019 for the first quarter, compared to a loss of $330,926 in 2019. The company also noted that gross profit as a percentage of revenue for the first quarter was 23.8%, up from 22.1% for the same quarter in 2019. 

Corp () (OTCQB:JGLDF) revealed Monday that it has now raised over C$7.5 million as it closed a second and final tranche of an oversubscribed placing for C$5 million, which will be used for exploration in the east Asian country. Thanking the investor base, John Proust, the firm’s chairman and CEO, told investors in a statement: “This financing will give Japan Gold the ability to initiate new drill programs on its wholly owned Ikutahara Project in Hokkaido and Ohra-Takamine Project in southern Kyushu concurrently with the country wide evaluation of 28 projects already being carried out under the Barrick Alliance.”

(NYSEAMERICAN:MMX) () announced its annual general meeting will be held on Tuesday June 30 at 2PM PST. The meeting includes a virtual component in response to COVID-19 where investor can dial in toll-free at 1-800-319-4610 in the US and Canada. Callers are advised to dial into the AGM at least 15 to 20 minutes ahead of the scheduled start time. 

Lexaria Bioscience Corp () (OTC:LXRP) announced Monday that it has retained PCG Advisory Inc of New York to provide investor relations and digital marketing services. PCG will develop a comprehensive investor relations strategy to increase investor awareness of Lexaria and amplify market visibility from veteran wall street professionals with deep market experience. PCG’s sectors of deepest experience include life sciences, technology, and cannabis. PCG will also introduce the company to its proprietary investment community network that includes institutional funds, investment banks, analysts and brokers. PCG is being engaged for an initial six-month contract and will receive US$5,500 per month.

Hill Street Beverage Company Inc () saw a 5% increase in its year-to-date net revenue despite retail pullback due to the coronavirus pandemic, according to its latest financial results posted on Monday. The Toronto-based infused beverage company posted net revenue of C$1.4 million for the nine months ended March 31, 2020, up 5% from the $1.3 million it put up during the same year-ago period. The firm made “important and prudent decisions” to bring its cost structure in line with anticipated revenues from the alcohol-free product segment while it begins construction on its cannabis production facilities, said CEO Terry Donnelly in a statement accompanying the news.

() announced Monday the deployment of its Multiscreen-as-a-Service (MaaS) platform at Baptist Health South Florida, the state’s second-largest employer. The healthcare organization operates seven hospitals and 50 outpatient and urgent care centers, including approximately 23,000 employees and more than 4,000 physicians. Deployment of Phunware’s MaaS platform at BHSF enables patients, staff and visitors to seamlessly engage with critical healthcare functions and navigate across more than 1.8 million square feet of medical facilities.

Codebase Ventures Inc () () subsidiary appointed brand and creative consultancy Propaganda to be Love Hemp brand’s marketing agency. The UK-based agency is a prominent and strategic creative consultancy that has been helping brands to build their presence and reputations for over 22 years. Propaganda will support Love Hemp to develop a brand strategy within the rapidly evolving CBD sector.

PreveCeutical Medical Inc () () has requested funding of C$29.5 million from the Canadian government to support the extension of its cannabis sol-gel program in a bid to battle the coronavirus (COVID-19) pandemic, it told investors Monday. The health sciences specialist has submitted a statement of interest to the Strategic Innovation Fund (SIF), Canada, providing an overview of its plans. SIF is providing financial support for a national medical research strategy to fight COVID-19 that includes vaccine development, the production of treatments, and tracking of the virus.

Nextleaf Solutions Ltd () () announced Monday that it has been issued more patents in North America, Asia, and Europe. The patents pertain to the company’s unique method of extracting and separating cannabinoids and terpenes, according to a statement. The additional patents were awarded in the US, Spain, Portugal, Poland, Malta, Ireland, Denmark and Cambodia.

Aequus Pharmaceuticals Inc () () posted first-quarter results on Monday that saw its revenue jump 76% year-over-year on the back of greater market access and higher sales volume.In a statement accompanying the numbers, Aequus Pharmaceuticals CEO Doug Janzen, said: “Today, the company reported record quarterly revenues of C$579,450 for the first quarter of 2020, a 76% increase in revenues compared to the first quarter in 2019.” Janzen put the strong revenue growth down to the company’s greater market access and higher sales volume.

Naturally Splendid Enterprises Ltd () () told shareholders Monday that it has a full inventory stock of possible coronavirus drug Cavaltinib. The Vancouver-based company is awaiting Health Canada’s go ahead to start a Phase 2 clinical trial for the treatment, which targets a severe immune reaction where the human body releases too many cytokines into the bloodstream very quickly, known as a cytokine storm. Naturally Splendid is teaming up with Biologic Pharmamedical Research to develop and pursue the clinical study using one of Biologic’s patented technologies as a candidate for a potential treatment. Naturally Splendid will have a 16% stake in the joint venture and be granted a 10% royalty on gross sales of all products and applications arising from the clinical study.

() (), North America’s only carrier-agnostic parcel pick-up and drop-off network, posted full-year results on Friday that saw its revenue jump 34.6% year-over-year on the back of increasing parcel volumes and new services. For its fiscal year ended February 29, 2020, the Toronto-based company reported revenue of $1.1 million, compared to 832,885 in fiscal year 2019. PUDO narrowed its full-year net loss to $2 million The company said the revenue bump could be attributed to a “significant increase in Failed First Attempt parcel volume and new PUDO services launched in FY 2020 offset by a 10.9% decrease in member shipments.”

() () has unveiled positive results from its Phase 2B clinical trial of flagship drug ATB-346, which was better than the placebo in reducing osteoarthritis (OA) pain. The drug met the primary endpoint in the dose-ranging, efficacy study, which involved 385 patients, the biotech firm said in a statement. Antibe is now planning another pivotal Phase 2/3 randomized, controlled trial to define the lowest effective dose of the drug.

Klondike Gold Corp () (FRA:LBDP) (OTCPINK:KDKGF) said it has commenced a 2020 exploration program at its Klondike District Property in the Yukon Territory in Canada. The group said diamond drilling is underway with approximately 9 holes targeting the Lone Star Zone in phase 1, while a phase 2 program targeting Stander Zone and a phase 3 program targeting Stander Zone extensions are also planned. The drilling is aiming to test for consistency in the grade of gold mineralization and provide data to allow consideration of a resource volume at the various targets.

Ltd () () is enrolling social media influencers in a bid to increase awareness of its Swiss-hosted cybersecurity and data privacy products, the group told investors on Monday. The tech firm has set itself an organic target of 5,000 users by the end of fiscal year 2021, which would bring in north of US$1.5 million in revenue (over C$2 million) per year in gross revenues. The company has launched a new so-called ‘Social Media Influencers Affiliate Program (SMIAP), which it is aiming to have fully deployed with influencers by the beginning of August this year.

CytoDyn Inc () said it has asked the US Food & drug Admi9nistration (FDA) to look at the group’s application to license its leronlimab drug as a combination therapy for HIV as a “priority review”. Under current legislation, the FDA has agreed to improve the time drugs are reviewed and has created a two-tiered system, comprising a standard and a priority review. A ‘priority’ designation means the regulator aims to take action on an application within six months, versus 10 months under a standard review.

() () has said it is preparing to restart field exploration at its Lost Cities-Cutucu project in Ecuador by June 10. The explorer noted that it has a team back in the mineral explorer’s field office in Macas ready to recommence its exploration program after suspending work in light of the coronavirus (COVID-19) pandemic. Toronto-based Aurania is getting ready to return to the field after using the mandated work stoppage to analyze LiDAR survey data from seven priority target areas on the expansive property.

() (OTCPINK:BVNNF), a dominant player in the cannabis-infused beverages market, said Friday that it has closed a non-brokered private placement to generate working capital and settled a $84,669.20 debt in exchange for shares. As a part of the equity financing, the Vancouver-based firm sold 88,235 common shares at a price of $0.425 per share for gross proceeds of $37,500 to generate general working capital. Separately, BevCanna also said it has settled debt in the amount of $84,669.20 owed by the company to certain creditors in exchange for 211,673 common shares at a deemed price of $0.40 per debt settlement share.

Corp () (OTCPINK:PEMTF) has said it plans to undertake a non-brokered unit share offering to raise up to C$5 million to help market and develop its CBD products in North America and Europe. The direct-to-consumer CBD provider anticipates offering up to around 11.1 million units, each containing one common share and one common share purchase warrant, at a price of C$0.45 per unit. The warrants are exercisable at a price of C$0.90 over the subsequent two years. “The company continues to look at future marketing opportunities and strategic consultants to grow awareness of the company and its activities,” CEO Ryan Hoggan said in a statement. “As a company, we look to disseminate accurate and in-depth information on our endeavors. We will look at marketing where appropriate and continue to do so with guidelines.”

NexTech AR Solutions Corp () () CEO Evan Gappelberg has purchased 100,000 company shares for his fourth buy this year, according to a statement Monday. The augmented reality (AR) specialist said Gappelberg purchased the shares by exercising 100,000 warrants, putting an additional $70,000 onto its balance sheet. His total investment so far for 2020 is $800,921. NexTech said the CEO’s investment further bolsters its cash and inventory position, which is already over $3 million.

(CVE:VLNS) () said it has entered into a syndicated credit facility that would provide it with up to C$40 million of secured debt financing. The Canadian Imperial Bank of Commerce is the co-lead arranger and administrative agent, and ATB Financial is the other co-lead arranger. Valens said the credit facility consists of a C$20 million secured term loan and a C$20 million secured revolving loan, with an accordion feature that could allow the cannabis company to increase the aggregate commitments by up to an additional C$10 million. The group said the proceeds from the credit facility will further strengthen its balance sheet, allowing for the continued expansion of its operations and execution of its corporate strategy, including gaining access to new domestic and global opportunities to increase shareholder value.

Technology Inc () (OTCQB:NTTCF) has provided an update on its audit process, saying it has been granted an additional 10-day extension to provide its audited financials. The company, which provides a transactional hub for cryptocurrency payments and equips businesses with technology to integrate crypto processing into their payment model without taking on the risk or volatility of the crypto market, said the extension had been granted for a number of reasons. In a statement, founder and chief executive Clayton Moore said: “In the past year, we’ve gone from doing $35,000 per month in transactions to exceeding that multiple times over in a single day. The audit process had to change as the substantive approach was no longer viable due to the sheer volume of transactions. As this is the first time that we have done an audit using the internal controls approach and the limitations put in place due to [coronavirus], the audit is taking longer than anticipated. While this is a lot more work for the company right now, moving forward we will have the road map in place for future audits.”

Humanigen, Inc., (), a clinical-stage biopharmaceutical company focused on preventing and treating cytokine storm with lenzilumab, the company’s proprietary Humaneered anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody, has announced that Dr  Durrant, the company’s chief executive officer, and Dr Dale Chappell, the company’s chief scientific officer, will present at the Jefferies 2020 Virtual Global Healthcare Conference on Thursday, June 4, 2020, at 3:00 p.m. ET in Virtual Track Room 7.

(), operator of financial markets for 10,000 U.S. and global securities, has announced that () (OTCQX:GLVMF), a company focused on project generation, has qualified to trade on the OTCQX Best Market and has today upgraded from the OTCQB Venture Market. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Graduating to the OTCQX Market from the OTCQB Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among US investors. Glenn J. Mullan, President/CEO of Golden Valley Mines commented: “We are thrilled with this enhancement to our OTC Markets profile, upgrading from the OTCQB Venture Market to the OTCQX Best Market. We see this as the logical next step in our evolution, and look forward to gaining more market awareness in the USA. The Company continues to assess marketing strategies to increase exposure and liquidity.”

() announced that it intends to rely on the temporary blanket relief for market participants published on March 23, 2020, by the Canadian Securities Administrators which provides for a 45-day extension to file its interim financial statements and interim Quarterly Management Discussion and Analysis for the quarter ended March 31, 2020. The company said it expects to file its Q1, 2020 Filings no later than June 15, 2020. Other than as previously disclosed, the company said there have been no material business developments since the date of the audited annual consolidated financial statements that were filed on May 29, 2020.

Ltd. () () has said it presently anticipates being able to complete and file its Q1 interim financial statements and corresponding management’s discussion and analysis (collectively,  for the three month period ended March 31, 2020. on or before July 15, 2020. The group noted that, in response to the coronavirus (COVID-19) pandemic, the securities regulatory authorities in Canada have granted a blanket exemption allowing issuers an additional forty-five days to complete their regulatory filings that were otherwise due during the period from March 23, 2020, to June 1, 2020.  The company confirmed that there have been no material business developments since April 24, 2020, when it filed its December 31, 2019, year-end audited financial results, other than as announced.

() (OTCPINK:OHFF) said it has not yet filed its audited annual financial statements, management discussion and analysis and related certifications for the year ended December 31, 2019, and will be relying on the full 45 days granted by the Blanket Relief by the securities regulatory authorities in Canada. The group added that there have not been any material business developments since the release of its third-quarter results in November 2019 other than as otherwise disclosed in Telson’s continuous disclosure filings and news releases.

() has said that it will delay the filing of its annual financial statements, related management discussion and analysis, and related CEO and CFO certifications for the thirteen months ended January 31, 2020, under the blanket relief for all market participants and reporting issuers as granted by the Canadian Securities Administrators and implemented by the relevant securities regulators. The company said it expects to file the annual filings on or about July 10, 2020. Other than as disclosed in the company’s news releases, the group confirmed that since the filings of its unaudited condensed interim consolidated financial statements for the ten-months ended October 31, 2019, there have not been any material business developments.

() () has said it is relying upon the exemption published by the British Columbia Securities Commission on March 23, 2020, for the requirement to file unaudited interim financial statements and management’s discussion and analysis on or before the 60th day after the end of its most recently completed interim period ended March 31, 2020, and anticipates it will file them on or before June 30, 2020. The company confirmed that there have been no undisclosed material business developments since May 29, 2020, the date of filing of its audited annual financial statements for the year ended December 31, 2019.

() (OTCMKTS:FLWPF) said it has postponed the filing of its first-quarter 2020 interim financial statements and related management discussion and analysis for the period ended March 31, 2020 and now expects to report and file first quarter 2020 earnings on or before June 15, 2020. In addition, the company announced that, in accordance with applicable corporate and securities laws, and stock exchange rules, it has decided to delay holding an annual general meeting of shareholders until a later date in the second half of 2020.

Eurolife Brands Inc. () has said it is still expecting to file its audited financial statements for the year ended December 31, 2019, by June 15, 2020, under the co-ordinated relief provided by the securities regulators, which consists of a 45-day extension for certain periodic filings, as announced by the Canadian Securities Administrators (CSA) on March 18, 2020. The company confirmed that there have been no material developments, other than those disclosed through news releases, since the filing of its interim financial statements for the period ended September 30, 2019.

One World Lithium Inc. (OTC:OWRDF) (CSE-OWLI) (CNSX:OWLI.CN) has said it estimates that its ts annual and interim financial statements and accompanying management’s discussion and analysis will now be filed on or prior to June 14, 202, after relying on the blanket relief providing a 45-day extension for periodic filings normally required to be made by issuers. The group confirmed that since the filing of its interim consolidated financial statements for the three months ended September 30, 2019, there have been no material business developments other than those previously disclosed through news releases.

() has said it continues to work with its auditors toward completing its annual filings by the extended deadline of June 15, 2020, as previously indicated. The company confirmed that as of the current date it is not aware of any other material information concerning its affairs which has not generally been disclosed.

CanaFarma Hemp Products Corp. () has said that under the blanket relief granted by the Canadian Securities Administrators it will not file its quarterly financial statements for the three month period ended March 31, 2020, and the related management’s discussion and analysis and officer certifications, prior to the filing deadline of June 1, 2020. The company said it expects to report its interim results on or about June 30, 2020. It added that, other than as disclosed in the company’s press releases, there have not been any material business developments since the date that the last financial statements were filed.

. (), (OTCMKTS:HLRTF) said that under the blanket relief granted by the Canadian Securities Administrators it will not file annual financial statements for the year ended December 31, 2019, and its quarterly financial statements for the three month period ended March 31, 2020, prior to the deadline of June 1, 2020. The company said it expects to file and deliver, as applicable, its annual filings on or about June 15, 2020, and its interim filings, on or about July 14, 2020. It added that, other than as disclosed in the company’s press releases, there have not been any material business developments since the date that the last financial statements were filed.